Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Cellular and clinical impact of haploinsufficiency for genes involved in ATR signaling.
Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 =50% who progress on first-line immunotherapy: real-world data from a European cohort.
Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients.
Rathmell, Jeffrey
De Novo Variants in SPOP Cause Two Clinically Distinct Neurodevelopmental Disorders.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
De Novo Variants in SPOP Cause Two Clinically Distinct Neurodevelopmental Disorders.
De Novo Variants in SPOP Cause Two Clinically Distinct Neurodevelopmental Disorders. Am J Hum Genet. 2020 03 05; 106(3):405-411.
View in:
PubMed
subject areas
Adolescent
Child
Child, Preschool
Facies
Female
Humans
Infant
Intellectual Disability
Male
Mutation, Missense
Neurodevelopmental Disorders
Nuclear Proteins
Repressor Proteins
Skull
Young Adult
authors with profiles
Daniela Del Gaudio